5-110528664-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001039763.4(TMEM232):āc.1627A>Gā(p.Ile543Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000612 in 1,535,084 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001039763.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM232 | ENST00000455884.7 | c.1627A>G | p.Ile543Val | missense_variant | 12/14 | 2 | NM_001039763.4 | ENSP00000401477.2 | ||
TMEM232 | ENST00000512003.7 | n.*997+39783A>G | intron_variant | 1 | ENSP00000427785.2 | |||||
TMEM232 | ENST00000515518.6 | n.1375+39783A>G | intron_variant | 1 | ||||||
TMEM232 | ENST00000508571.6 | n.1018+39783A>G | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152166Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000298 AC: 4AN: 134018Hom.: 0 AF XY: 0.0000137 AC XY: 1AN XY: 72990
GnomAD4 exome AF: 0.0000615 AC: 85AN: 1382918Hom.: 0 Cov.: 31 AF XY: 0.0000645 AC XY: 44AN XY: 682402
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152166Hom.: 1 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74326
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2023 | The c.1627A>G (p.I543V) alteration is located in exon 12 (coding exon 11) of the TMEM232 gene. This alteration results from a A to G substitution at nucleotide position 1627, causing the isoleucine (I) at amino acid position 543 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at